Bovine lactoferrin reduces visceral fat and liver triglycerides in ICR mice

Journal of Oleo Science

Volumn 62, Issue 2, 2013, Pages 97-103

  Morishita, Satoru ^a,c   Ono, Tomoji ^a   Fujisaki, Chikako ^a   Ishihara, Yasuharu ^a   Murakoshi, Michiaki ^a,b   Kato, Hisanori ^c   Hosokawa, Masashi ^d   Miyashita, Kazuo ^d   Sugiyama, Keikichi ^a,e   Nishino, Hoyoku ^b,e  

^a LION CORPORATION   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

Lactoferrin; LRP1; Mesenteric fat; Visceral fat

Indexed keywords

ADIPOCYTES; ANIMAL MODEL; ANTI-ADIPOGENIC ACTIVITIES; BOVINE LACTOFERRIN; CLINICAL TRIAL; FAT TISSUE; FATTY ACID METABOLISM; IN-VITRO; LACTOFERRIN; LIVER TRIGLYCERIDES; LRP1; MESENTERIC FAT; MULTI-FUNCTIONAL; SMALL INTESTINE; TRIGLYCERIDE LEVELS; VISCERAL FAT;

TISSUE;

MAMMALS;

LACTOFERRIN; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE ABSORPTION; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; INTESTINAL ABSORPTION; INTRA-ABDOMINAL FAT; LACTOFERRIN; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED ICR; TRIGLYCERIDES;

MLCS; MLOWN;

EID: 84873620803     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.62.97     Document Type: Article

References (23)

1. Tomita, M.; Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H. and Kawase, K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci. 74, 4137-4142 (1991).
2. Harmsen, M. C.; Swart, P. J.; de Bethune, M. P.; Pauwels, R.; De Clercq, E.; The, T. H. and Meijer, D. K. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis. 172, 380-388 (1995).
3. Zimecki, M.; Wlaszczyk, A.; Cheneau, P.; Brunel, A. S.; Mazurier, J.; Spik, G. and Kubler, A. Immunoregulatory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals. Arch Immunol Ther Ex (Warsz). 46, 231-240 (1998).
4. Shoji, H.; Oguchi, S.; Shinohara, K.; Shimizu, T. and Yamashiro, Y. Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res. 61, 89-92 (2007).
5. Sekine, K.; Ushida, Y.; Kuhara, T.; Iigo, M.; Baba-Toriyama, H.; Moore, M. A.; Murakoshi, M.; Satomi, Y.; Nishino, H.; Kakizoe, T. and Tsuda, H. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121, 211-216 (1997
6. Moreno-Navarrete, J. M.; Ortega, F. J.; Bassols, J.; Castro, A.; Ricart, W. and Fernandez-Real, J. M. Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem. 54, 301-309 (2008
7. Kawashima, M.; Kawakita, T.; Inaba, T.; Okada, N.; Ito, M.; Shimmura, S.; Watanabe, M.; Shinmura, K. and Tsubota, K. Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice. PLoS One. 7, e33148 (2012).
8. Takeuchi, T.; Shimizu, H.; Ando, K. and Harada, E. Bovine lactoferrin reduces plasma triacylglycerol and NEFA accompanied by decreased hepatic cholesterol and triacylglycerol contents in rodents. Br J Nutr. 91, 533-538 (2004).
9. Yagi, M.; Suzuki, N.; Takayama, T.; Arisue, M.; Kodama, T.; Yoda, Y.; Numasaki, H.; Otsuka, K. and Ito, K. Lactoferrin suppress the adipogenic differentiation of MC3T3-G2/PA6 cells. J Oral Sci. 50, 419-425 (2008).
10. Kodama, H. A.; Amagai, Y.; Koyama, H. and Kasai, S. A new preadipose cell line derived from newborn mouse calvaria can promote the proliferation of pluripotent hemopoietic stem cells in vitro. J Cell Physiol. 112, 89-95 (1982).
11. Moreno-Navarrete, J. M.; Ortega, F. J.; Ricart, W. and Fernandez-Real, J. M. Lactoferrin increase (172Thr) AMPK phosphorylation and insulin-induce (p473Ser) AKT while impairing adipocyte differentiation. Int J Obe (Lond). 33, 991-1000 (2009
12. Ono, T.; Morishita, S.; Fujisaki, C.; Ohdera, M.; Murakoshi, M.; Iida, N.; Kato, H.; Miyashita, K.; Iigo, M.; Yoshida, T.; Sugiyama, K. and Nishino, H. Effects of pepsin and trypsin on the anti-adipogenic action of lactoferrin against pre-adipocytes derived from rat mesenteric fat. Br J Nutr. 105, 200-211 (2011).
13. Ono, T.; Murakoshi, M.; Suzuki, N.; Iida, N.; Ohdera, M.; Iigo, M.; Yoshida, T.; Sugiyama, K. and Nishino, H. Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr. 104, 1688-1695 (2010).
14. Shi, J.; Finckenberg, P.; Martonen, E.; Ahlroos-Lehmus, A.; Pilvi, T. K.; Korpela, R. and Mervaala, E. M. Metabolic effects of lactoferrin during energy restriction and weight regain in diet-induced obese mice. Journal of Functional Foods. 4, 66-78 (2012)
15. Masson, O.; Chavey, C.; Dray, C.; Meulle, A.; Daviaud, D.; Quilliot, D.; Muller, C.; Valet, P. and Liaudet-Coopman, E. LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue. PLoS One. 4, e7422 (2009).
16. Herz, J. and Strickland, D. K. LRP: a multifunctional scavenger and signaling receptor. J Clin Invest. 108, 779-7784 (2001).
17. Grey, A.; Banovic, T.; Zhu, Q.; Watson, M.; Callon, K.; Palmano, K.; Ross, J.; Naot, D.; Reid, I. R. and Cornish, J. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol. 18, 2268-2278 (2004).
18. Lii, C. K.; Huang, C. Y.; Chen, H. W.; Chow, M. Y.; Lin, Y. R.; Huang, C. S. and Tsai, C. W. Diallyl trisulfide suppresses the adipogenesis of 3T3-L1 preadipocytes through ERK activation. Food Chem Toxicol. 50, 478-484 (2012).
19. Takeuchi, T.; Kitagawa, H. and Harada, E. Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult rats. Exp Physiol. 89, 263-270 (2004
20. Fischer, R.; Debbabi, H.; Blais, A.; Dubarry, M.; Rautureau, M.; Boyaka, P. N. and Tome, D. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues. Int Immunopharmacol. 7, 1387-1393 (2007).
21. Crawford, S. E. and Borensztajn, J. Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrinsensitive and apolipoprotein E-independent pathway. J Lipid Res. 40, 797-805 (1999).
22. Descamps, O.; Bilheimer, D. and Herz, J. Insulin stimulates receptor-mediated uptake of apoE-enriched lipoproteins and activated alpha 2-macroglobulin in adipocytes. J Biol Chem. 268, 974-981 (1993).
23. Hofmann, S. M.; Zhou, L.; Perez-Tilve, D.; Greer, T.; Grant, E.; Wancata, L.; Thomas, A.; Pfluger, P. T.; Basford, J. E.; Gilham, D.; Herz, J.; Tschop, M. H. and Hui, D. Y. Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice. J Clin Invest. 117, 3271-3282 (2007).